Economic benefits of subcutaneous trastuzumab administration: A single institutional study from Karolinska University Hospital in Sweden

por Hedayati, Elham, Fracheboud, Lionel, Srikant, Vaidyanathan, Greber, David, Wallberg, Susanne, Linder Stragliotto, Christina
Publicado 2019

Evaluation of PD-L1 Expression in Undifferentiated Pleomorphic Sarcomas, Liposarcomas and Chondrosarcomas

por Zhang, Yifan, Chen, Yi, Papakonstantinou, Andri, Tsagkozis, Panagiotis, Linder-Stragliotto, Christina, Haglund, Felix
Publicado 2022

The role of neoadjuvant imatinib in gastrointestinal stromal tumor patients: 20 years of experience from a tertial referral center

por Renberg, Sara, Zhang, Yifan, Karlsson, Fredrik, Bränström, Robert, Åhlen, Jan, Jalmsell, Li, Linder‐Stragliotto, Christina, Haglund de Flon, Felix, Papakonstantinou, Andri
Publicado 2022

Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors

por Fröbom, Robin, Berglund, Erik, Berglund, David, Nilsson, Inga-Lena, Åhlén, Jan, von Sivers, Karin, Linder-Stragliotto, Christina, Suenaert, Peter, Karlsson-Parra, Alex, Bränström, Robert
Publicado 2020